Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/2000
11/02/2000WO2000064885A1 Heteroaryl diazacycloalkanes, their preparation and use
11/02/2000WO2000064538A1 Products and methods for brachytherapy
11/02/2000WO2000064491A1 4-fluoroalkyl-3-halophenyl nortropanes
11/02/2000WO2000064490A1 Fluoroalkenyl nortropanes
11/02/2000WO2000064480A1 Treatment, imaging and diagnosis of disease using an agent which binds alfa5-integrin
11/02/2000WO2000064439A1 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity
11/02/2000EP1048302A2 Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease
11/02/2000EP1047708A1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center
11/02/2000EP1047457A2 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
11/02/2000EP1047456A1 A method and composition for cancer treatment by enzymatic conversion of soluble radioactive toxic agents
11/02/2000EP1047455A1 Para-hydrogen labelled agents and their use in magnetic resonance imaging
11/02/2000EP0662148B1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
11/02/2000CA2370600A1 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity
11/02/2000CA2369663A1 4-fluoroalkyl-3-halophenyl nortropanes
11/02/2000CA2367695A1 Heteroaryl diazacycloalkanes, their preparation and use
10/2000
10/30/2000CA2307081A1 Radiotracers for in vivo study of acetylcholinesterase and alzheimer's disease
10/26/2000WO2000063416A2 F18-labeled oxa fatty acids and methods of making and using the same
10/26/2000WO2000063210A1 Morphinoid compounds
10/26/2000WO2000062808A2 Cobalamin conjugates useful as antitumor agents
10/26/2000CA2370419A1 Cobalamin conjugates useful as antitumor agents
10/25/2000EP1046401A2 Fatty acid derivative labelled with a radioactive transition metal
10/25/2000EP1045838A1 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid
10/25/2000EP1045675A2 In-situ radioactive stent
10/25/2000EP0914042A4 Cluster clearing agents
10/25/2000EP0592549A4 Tissue specific imaging agents using internal image anti-idiotypic antibodies
10/24/2000US6136782 Multimeric antithrombotic agents
10/24/2000US6136548 Mutating one or more amino acids of tissue plasminogen activator, then measuring binding of mutant to beta amyloid peptide and to fibrin; improved mutant binds fibrin but does not bind beta-amyloid peptide; for alzheimer's patients
10/24/2000CA2031891C Intra-arterial stent with the capability to inhibit intimal hyperplasia
10/20/2000CA2306179A1 Fatty acid derivative labeled with a radioactive transition metal
10/19/2000WO2000062071A1 Diagnostic and therapeutic use of antibodies against the urokinase receptor
10/19/2000WO2000061635A2 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061197A1 Assessment of gastric emptying disorders
10/19/2000WO2000061196A2 Fatty acid analogs for diagnosis of coronary artery disease
10/19/2000WO2000061195A1 Benzodiazepine derivatives for imaging thrombi
10/19/2000CA2372171A1 Benzodiazepine derivatives for imaging thrombi
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2369484A1 Assessment of gastric emptying disorders
10/18/2000EP1044692A1 Process and device for dry application of products to inhalable powdery supports
10/18/2000EP1044025A2 Nuclear scintigraphic assessment of mucosal function
10/18/2000EP1043975A1 Magnetically responsive composition
10/18/2000EP1043928A1 Methods and compositions for treating and diagnosing tumors using adenosine receptor activated cells
10/18/2000EP0963182A4 Method of treating a disease process in a luminal structure
10/18/2000EP0827513A4 Methods of treatment and diagnostic visualisation, particularly in cancer
10/18/2000EP0467932B1 Urokinase-type plasminogen activator receptor
10/18/2000CN1057470C Ether isonitriles and radiolabeled complexes thereof
10/17/2000US6132764 Targeted polymerized liposome diagnostic and treatment agents
10/17/2000US6132750 Particles of cross-linked proteins and polysaccharides with hydroxamic groups for chelating metals and their uses notably in cosmetics
10/17/2000US6132698 Stabilized solution of colorless organic compound with beta emitting nuclide of phosphorous and sulfur
10/17/2000US6132697 Radiopharmaceutical compositions capable of localizing at sites of thrombus
10/17/2000US6132677 Radioactive articles of isotopes, extrusion and drawing
10/12/2000WO2000059550A2 Indium-114m and related compositions applicable in brachytherapie
10/12/2000WO2000059548A1 Polyethyleneimine:dna formulations for aerosol delivery
10/12/2000WO2000059547A2 Method of detecting endometriosis
10/12/2000WO2000033874A3 Boron neutron capture therapy using pre-targeting methods
10/12/2000WO2000023594A9 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
10/12/2000WO2000018440A9 Somatostatin receptor radioligand with increased uptake
10/12/2000WO1999064039A9 Bradykinin antagonists
10/12/2000DE19914101C1 Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik Perfluoralkylamide, their preparation and their use in the diagnosis
10/12/2000CA2368185A1 Polyethyleneimine:dna formulations for aerosol delivery
10/12/2000CA2366774A1 Method of detecting endometriosis
10/11/2000EP1042252A1 Method for making apatite ceramics, in particular for biological use
10/11/2000EP1042003A1 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
10/11/2000EP0713513B1 Tris(isonitrile)copper(i) sulfates for preparing radionuclide complexes
10/05/2000WO2000057924A2 Colloid for scintigraphy
10/05/2000WO2000057923A2 Radioactive seed with multiple markers and method for using same
10/05/2000WO2000057916A1 Sphingomyelin containing preparation for the enhancement of tumor therapy
10/05/2000WO2000057890A1 Pulmonary delivery of protonated/acidified nucleic acids
10/05/2000WO2000057787A2 Method for localization of blood clots
10/05/2000CA2707691A1 Sphingomyelin containing preparation
10/05/2000CA2364753A1 Method for localization of blood clots
10/04/2000EP1039929A1 Activated t-cells and their uses
10/04/2000EP0999782A4 A breath test for the diagnosis of bacterial infection
10/03/2000US6127530 Efficient reduction in the presence of a reducing agent, a macromolecule which adjusts reaction equilibrium to favor the reduction state, and a ligand which can form a complex with the radionuclide in its reduced state
10/03/2000US6127527 Apparatus for the therapeutic use of 213 Bi
10/03/2000US6127126 Detection or tumors in brain cells; screening for nucleotide sequences that code mutant proteins, detecting tumors in sample
10/03/2000US6126946 Hepatocyte-selective oil-in-water emulsion
10/03/2000US6126918 Screening assays to identify therapeutic agents for amyloidosis
10/03/2000US6126917 Epidermal growth factor receptor binding compounds for positron emission tomography
10/03/2000US6126916 Radiometal-binding peptide analogues
10/03/2000US6126909 Process and apparatus for the production of BI-212 and a use thereof
09/2000
09/28/2000WO2000056773A1 Antibodies specific for cyp1b1
09/28/2000WO2000056770A1 ANTI-p53 ANTIBODIES
09/28/2000WO2000056723A1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
09/28/2000WO2000056369A1 Radioactive cisplatin in the treatment of cancer
09/28/2000WO2000026394A9 Variants of humanized anti-carcinoma monoclonal antibody cc49
09/28/2000DE19913978A1 Asymmetric stent containing irregularly distributed active agents or radioisotopes useful e.g. for treating atherosclerosis and preventing restenosis
09/28/2000CA2366938A1 Radioactive cisplatin in the treatment of cancer
09/28/2000CA2365121A1 Antibodies specific for cyp1b1
09/28/2000CA2365104A1 Anti-p53 antibodies
09/28/2000CA2362703A1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
09/27/2000EP1038300A1 Highly radioactive miniaturized ceramic strontium 90 radiation source and method for the production thereof
09/27/2000EP0788377B1 Radiolabelled glucans
09/27/2000EP0688224B1 A mutant crp-protein and methods and materials for making and using it
09/26/2000US6124440 Cores for technetium radiopharmaceuticals
09/26/2000US6123917 Useful in biochemical assays, imaging techniques, and in a wide variety of drug treatment methodologies
09/26/2000US6123916 For treating disorders with an aetiology comprising or associated with excess of gh-secretion
09/26/2000US6123068 Systems for the intrapulmonary delivery of aerosolized aqueous formulations
09/21/2000WO2000055633A2 Methods of screening for colorectal cancer modulators
09/21/2000WO2000025819A9 Enhanced radiation therapy
1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 243